LYON JOSEPH DOUGLAS (Chief Accounting Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 6/3/2026ACC: 0001193125-26-256022
Officer· Chief Accounting Officer
Since Jul 2020
+805.00
Net shares
Net buyer
$18.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.07K acquired · 269.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+537.00
Price / share
$70.44
Trade value
$37.83K
% of position
8.6%
6/1/2026
6.23K→6.77K
Common Stock
Direct
Shares
+537.00
Price / share
—
Trade value
—
% of position
7.9%
6/1/2026
6.77K→7.30K
Common Stock
Direct
Shares
−269.00
Price / share
$70.44
Trade value
$18.95K
% of position
3.7%
6/2/2026
7.30K→7.04K
Total
Net shares
+805.00
Net value
$18.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | A · Award | +537.00 | $70.44 | $37.83K | 8.6% | 6.23K | 6.77K |
| Common Stock Direct | 6/1/2026 | A · Award | +537.00 | — | — | 7.9% | 6.77K | 7.30K |
| Common Stock Direct | 6/2/2026 | F · Tax Withholding | −269.00 | $70.44 | $18.95K | 3.7% | 7.30K | 7.04K |
| Total | +805.00 | $18.88K | ||||||
Derivative Transactions0
No derivative transactions reported